"Methods:" In this mouth split double-blind randomized clinical trial study, non-smoker patients of both genders (20 patients of each) between the age of 18 and 41 years who had plan to undergo surgery for both impacted mandibular third molars were selected. No patient was taking birth controls. Under local anesthesia both impacted teeth were removed and for each patient 0.2% CHX gel was placed in one socket. In the other socket a Gel placebo was applied, considered as control group. All patients were evaluated on forth and seventh days postoperatively for clinical evaluation of AO and also pain and swelling on given questionnaire, respectively.
"Results:" A 56% decrease in postoperation AO in the gel group was observed (P=0.453). The control group had 12.5% incidence postoperative AO, while the gel group had 5%. The difference was not statistically significant. No statistically significant differences were found in postoperative pain and swelling between two groups.
"Conclusion:" Topical intra-alveolous application of 0.2% CHX gel following the surgery of impacted mandibular third molars may decrease the incidence of AO. To obtain statistically significant results, further studies using more samples are needed.